” Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones. ‘
” There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with symptoms similar to pediatric ADHD such as impulsivity, distractibility and difficulty paying attention, following instructions and meeting deadlines, is the next big thing “.
Every 14 minutes, a person is killed by prescription drugs…
” Every 14 minutes, a person is killed by prescription drugs — and unlike most other causes of preventable death, which have been on the decline for years, medication-induced deaths are on the upswing across the US. According to a recent analysis conducted by the Los Angeles Times, drug-induced deaths have become so prevalent that their average yearly total now exceeds the number of deaths caused by traffic accidents “.
” It’s the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs….we don’t test drugs adequately for them. In the last few decades, we’ve been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for “vulnerable populations,” like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. “
The AllTrials transparency campaign says it is at a crossroads and is looking to take the next step into becoming a larger force against the restriction of clinical trial data by pharma. It continues: “There are many who hope that AllTrials will fizzle out and go away, as previous efforts have done – what happens next is up to all of us. We need your help to grow internationally, and to push for a decisive and permanent change.”
” Gueriguian testified that Eli Lilly knew as early as 1998 that Zyprexa increased the risk of developing diabetes, but did not issue warnings about those effects until 2007… ‘Simply put, it’s putting profit over the concern of the consumer‘, Gueriguian said “.
Around half of all clinical trials have not been published; some trials have not even been registered. If action is not taken urgently, information on what was done and what was found in trials could be lost forever, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated unnecessarily.
In 2008, in a little village in France, the mayor decided to take action and to move to bio food for their school… so that tomorrow, their children will not accuse them…
For the first time ever, our children are growing up less healthy than we are. As the rate of cancer, infertility and other illnesses linked to environmental factors climbs upward each year, we must ask ourselves: why is this happening?
The Diethylstilbestrol tragedy thorough historical review
For a thorough historical review of the DES tragedy take a moment and read this lengthy call for tighter FDA regulation of the drug industry. The DES story makes a compelling case!
DES Action USA commented: ” Thank you for this call for stronger government regulation of pharmaceuticals. The DES tragedy makes a compelling case and you tell the story well. Adding insult to injury, it isn’t correct to say that in 1971 the FDA banned DES for most uses. Sadly, DES was only ‘contraindicated’ so it was well into the 1970s before doctors stopped prescribing DES to pregnant women! Either they didn’t get the word, or they felt they knew better than government regulators. Many doctors now dismiss DES exposure as ‘not a problem anymore’ but millions of us were exposed before birth and live with the health problems it caused. We fervently wish similar tragedies wouldn’t happen again – but sadly, the DES lessons learned are being ignored. ”